Dermatologicals is set to record a value decline in 2020, compared to growth of 3% in 2019. Some of this lower consumption is due to environmental factors, however, the outbreak of COVID-19 impacted several areas.
With the outbreak of COVID-19 impacting several areas in 2020, an overall decline in dermatologist is also linked to a demographic and environmental factors. Therefore, the consumption of certain products is aligned to seasons, rather than being evenly distributed across the year.
Trimb Healthcare AB is set to retain its lead in 2020, increasing its share due to the strong positions of its brands Scheriproct and Propyless. In the current state of dermatologicals, with a low level of product innovation and few new entries, the main way to increase share is acquisition, a strategy the player followed over the review period.
Following a predicted decline in 2020, an uplift in growth will be seen from 2021, with value growth set to remain positive for the rest of the forecast period. The bulk of growth over the forecast period will be driven by antiparasitics/lice (head and body) treatments, with social distancing measures taking place in 2020, reducing the demand for these items during that year.
Antipruritics is set to recover in 2021, moving from a predicted decline in 2020 to positive growth the following year. A stable performance is then expected to be in place across the forecast period.
Demand for OTC nappy (diaper) rash treatments is set to recover in 2021, following a predicted decline for 2020. With the health and wellness trend being boosted by the outbreak of COVID-19, many Swedish parents will become increasingly concerned about the types of paediatric products that they are using on young children.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Medicated Skin Care industry in Sweden with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Medicated Skin Care industry in Sweden, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Medicated Skin Care research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page